Where does Jiva Pharma Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jiva Pharma Inc. ranks #32,174 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jiva Pharma Inc. hold?

Jiva Pharma Inc. holds 8 US utility patents granted between 2016 and 2021, spanning 5 technology areas.

What is Jiva Pharma Inc.'s Innovation Score?

Jiva Pharma Inc. has an Innovation Score of 21.4 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Jiva Pharma Inc. focus on?

Jiva Pharma Inc.'s top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 6 patents. Grants appear in 5 CPC subclasses total.

Is Jiva Pharma Inc.'s patent grant rate increasing or decreasing?

Jiva Pharma Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Jiva Pharma Inc.'s patents?

Jiva Pharma Inc.'s patents average 9.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jiva Pharma Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Jiva Pharma Inc.

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jiva ranks #32,174 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#32,174
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.4/100): 9.8
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32174 · US Corporation #32,174 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,174/49,997
PHOTO-FINISH Jiangsu Hengxin…
CPC-NARROW C07C · 5 areas
INNOV-THIN 21.4/100
CLAIMS-PAR 9.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jiangsu Hengxin Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Jiva Pharma · this assignee

21
3D Lighting… · lowest

7

What this shows Jiva's Innovation Score is 21.4/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Jiva's grants concentrate

Jiva Pharma Inc. is a focused PatentsView assignee: 5 CPC subclasses with 75% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Jiva sits between Jiangsu Hengxin Technology Co., Ltd. and Johnson Controls Metals and Mechanisms GmbH & Co. KG.

Jiangsu Hengxin T…

8
Jiangsu Transimag…

8
Jina Pharmaceutic…

8
Jinjiang Beisite…

8
Johann Haltermann

8
John Evans' Sons…

8
Johnson Controls…

8
Johnson Controls…

8
Jiva Pharma ◀

8

What this shows Jiva holds 8 patents at rank #32,180, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jiva

By rank, the assignees closest to #32,180 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Jiva's primary technology class.

Jiva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Jiva Pharma Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	12.5%
2017	4	50.0%
2018	1	12.5%
2020	1	12.5%
2021	1	12.5%

Which technologies does Jiva Pharma Inc. patent most?

C07C - Acyclic OR Carbocyclic Compounds 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C07D - Heterocyclic Compounds 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#32,174

of 49,997 tracked assignees

Innovation Score

21.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Jiva Pharma Inc.'s patent record in context - here's where to go next.

Jiva Pharma Inc.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 75% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #32,174 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jiva Pharma Inc. against Jiangsu Hengxin Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.